Legal & General Group PLC Vincerx Pharma, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.0 - $1.72 $0 - $2,335	-1,358 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.0 - $0.0 $0 - $0	-430 Reduced 24.05%	1,358 $2,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	438 Added 32.44%	1,788 $18,000
Q3 2021 Nov 15, 2021	BUY	$0.0 - $0.0 $0 - $0	809 Added 149.54%	1,350 $22,000
Q2 2021 Aug 12, 2021	BUY	$0.0 - $27.0 $0 - $14,607	541 New	541 $7,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.